Peptide library / AICAR

AICAR

AICAR, or acadesine, is a small-molecule adenosine analog that is converted intracellularly to ZMP and can influence AMPK signaling; it is not a peptide.

Peptide & blend guide

The short version

Why people discuss it
Discussed for endurance, exercise-mimetic effects and metabolic/glucose-related goals. Community interest does not establish benefit or a suitable treatment.
What it is
AICAR, or acadesine, is a small-molecule adenosine analog that is converted intracellularly to ZMP and can influence AMPK signaling; it is not a peptide.
Biggest caution
Cell-signaling and animal-performance findings are not a human exercise protocol. Clinical acadesine research, laboratory AICAR exposure and products sold for performance use are not interchangeable.
Stack context
Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Sources report different amounts or schedules; the reference below is a named example, not a consensus.

Subcutaneous injection

Community reference · Not clinical guidance
Amount
10–25 mg
Frequency
Once daily or every other day
Duration / phase
2–4 weeks

Legacy community convention. PeptideDosages instead describes 1–3 mg daily over 8 weeks; another older combination example uses 2.5–5 mg for 4–8 weeks. No established subcutaneous dose-response evidence resolves the difference. Reference only; this does not establish safety, effectiveness or individual suitability.

Reference source · reviewed 2026-09-12
Compare reported schedules

Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.

Evidence & sources · Community source profile

AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.

Back to the peptide library